Mr. Stojecki,who was 63 years old from Poland, came to ZMKS for one course of DC-CIK treatment that includes six times of cell infusion.He sufferred from colon canc er with metastases in hte liver and lung. Previously, he recieved the surgery and several rounds of chemotherapy. However, the theraeutic effect was not so good. on account of his age and weak body, he could not tolerate the serious side effects of chmeotherapy and the surgical trauma any more.Therefore, he came to our medical center to recieve the latest therapy without any side effects.
He enjoys Chinese food very much.Before he returning to Poland, he bought many gifts in Beijing. During the course of treatment, he has been maintaiing a stable condition and be away from any side effects of cell-based immunotherapy. He spoke highly of our customer service's patience and kindness and the medical staff' warmth in the hospital.Besides, he decided to recieve another course of treatment after some time.
Mr. Stojecki and Yuki (the patients' customer service from our medical center) in front of the Imperial Palace
In 2008, a patient named Daisy from America complained of abdominal pain and vaginal bleeding and was admitted to a hospital in China. Then, she received a series of examinations and the CT scan showed that there was presence of a mass measuring5*6cm in pelvic cavity. The biopsy further confirmed it as squamous cell carcinoma. On the basis of her previous medical documents, she was diagnosed with cervical cancer four years ago and received several courses of chemotherapy and radiotherapy. Then, the experts made a consultation about her case and then she received cryotherapy subcutaneously under the guidance of ultrasound. The surgery went smoothly and Daisy had a good recovery. Three months later, Daisy went to the hospital for the check-up and the results indicated that the tumor shrunk obviously with a size of 3*3cm. In order to prevent the development of reoccurrence, Daisy received two courses of biological immunotherapy to consolidate the therapeutic effect. To every one’s joy, there is absence of signs of metastasis six months later and she stayed healthy until now.
The medical personnel and Mrs. Daisy at her birthday party along with her family members
Mr. Malcolm, who was 66 years old, was diagnosed with colon cancer in January, 2007. Then, he received the sigmoidectomy, partial excision of left artery and ureter. Unfortunately, infiltrating colon cancer with low differentiation developed after the surgery and the tumor reoccurred after one year. The imaging tests showed that the tumor had invaded the psoas major and further produced the blockage of ureter. However, the examination indicated that the cancer cells were still spreading after he received the chemotherapy. Finally, the doctor had choice but to suggest giving up further treatment.
Actually, his condition is not as bad as imagined and the God opened another window for him. In March, 2008, Malcolm came to China for better treatment. After a series of careful analysis, a panel of experts who in charge of his case made a personalized treatment plan on the basis of his special condition: a combined therapy of argon-helium knife (a kind of minimal invasive surgery), mild chemotherapy, gene therapy, anti-angiogenesis therapy and biological immunotherapy. Enlarged lymph nodes around the inguinal region disappeared and the lumps in the pelvic cavity necrosed after the treatment, along with the absence of pain. In general, Mr. Malcolm was very satisfied with the overall therapeutic effect. Two months later, he was discharged from the hospital and he returned to his own country. He is still healthy and alive till now.
Mr. Stringer, who is a very positive & optimistic Westerner. As an owner of a multi-national company, he is a frequent international traveler between Los Angeles, USA and Beijing, China. With the gracious supports from his wife & family, he had undergo DC-CIK immunotherapy & traditional Chinese medicine treatment at WuJin hospital Beijing after diagnosised with stage IV colon cancer in 2010
Buffett, the American business magnate, investor, and philanthropist, who is widely considered the most successful investor of the 20th century of the United States, has been diagnosed as prostatic carcinoma and is in good condition currently.
Introduction:
Buffett, the business magnate of the United States, wrote a letter to the stockholders of Bershire Hathaway Inc. that he had been diagnosed as prostatic carcinoma in 17th, April. However, he said optimistically in the letter that he was feeling pretty good and his current condition was not life-threatening. He stated in the letter that…
Buffett, considered the most successful investor of the 20th century of the United States, wrote a letter to the stockholders of Bershire Hathaway Inc. that he had been diagnosed as prostatic carcinoma in 17th, April. However, he said optimistically in the letter that he was feeling pretty good and his current condition was not life-threatening. Beffett stated in the letter that he had been diagnosed as the first stage of prostatic carcinoma in the 11th day of this month. The doctor decides to start a period of two months of radiotherapy from mid-July. What’s more, Buffett indicated that cancer had not spread yet and he was feeling well presently. He said that “my current condition is almost as same as previous healthy state and I am still energetic.”
Recently, ZMKS tumor cells targeted therapy technology summit conference was hosted in Jiuhua, Shanzhuang, Beijing. This seminar was chaired by the most famous cancer expert and academician Sun Yan, from Oncology Hospital of the Chinese Academy of Medical Sciences. At the conference, Luo Rongcheng, director of the cancer center of the South Hospital, explained the new technology of international targeted cancer therapy treatment. The founder of ACTL technology, Professor Liu Yong who came from Stanford University. Professor Liu introduced the new technology of ACTL tumor cells targeted therapy. More than 200 delegates from over hundred hospitals had attend. After the seminar, Professor Liu was invited to do an interview, with the treatment procedure, and application prospect of new technology of ACTL tumor cells targeted therapy.
Narration:
Journalist： Professor Liu，you had just introduced us this newly developed technology. Could you also tell us what type of patients are suitable or not suitable for this treatment?
DC-CIK Immunotherapy can kill residual cancer cells
Dendritic cell (DC) is the most powerful antigen-presenting cell in human body. It is the major antigen-presenting cell in innate immunity and play an important role in cancer suppression. Cytokine Induced Killer (CIK) is the lymphocyte, present in human blood, after a certain time to develop an immune active cells. Immune system is taken seriously more and more in the body against tumors. The DC-CIK cancer treatment Immunotherapy is called the fourth cancer treatment modality for this.
DC + CIK cells immune therapy is the most scientific method of treatment in patients with advanced cancer therapy of autoimmune cells, through advanced blood cell separator to extract the patient's own peripheral blood mononuclear cells, and high standards of GMP in the studio station, with a variety of cytokines induced by specific tumor antigen, the formation of activated The DC, CIK cells, both with training, can promote each other, so a lot of amplification, cell number and quality are significantly improved; the two re-order double output, but also their duties complement each other greatly improved Identify the body kill tumor cell function, to achieve better outcomes.
At present, clinical, cancer prognosis evaluation for the standard to 5-year survival after treatment for clinical cure standards. By a large number of domestic and international sample assessment of medical cases, DC + CIK treatment of autoimmune cell biology techniques, the prognosis for the situation, much higher than surgery alone or radiotherapy and chemotherapy clinical cure standards.
The DC-CIK cell therapy, cells with a precise role in killing tumor cells. In first developed, with high proliferative capacity and high cytotoxic activity of anti-tumor immune cells. Treatment of autoimmune cells CLS technology uses a unique dual-input dual-raising method, DC, CIK cells cultured double, double back to the transmission, clinical application to obtain a good therapeutic effect.
Cancer Therapy China is growing strong in its second year and trying to keep the cancer patients strong along with it.
Cancer Therapy China is celebrating its second anniversary wth offering a discounted program on CIK immunotherapy treatment to international patients.
"We are trying to make it easy for cancer patients to seek for immunotherapy," Cancer Therapy China General Manager Dr. Li said.
CIK immunotherapy will be offered at a lower rate to cancer patients who seeks for cancer treatment after their surgery resection, and especially those who are non-responsive to chemo & radio therapy.
Yet, as it celebrates its short past, the staff at Cancer Therapy China is already looking to the future
We are pleased to annouce the AAV-DC-CTLTM Tumor Cell Targeting Therapy (ACTLTM) the new breakthrough in tumor therapy is currently available at Cancer Therapy China. The most promosing, and cutting-edged immunology cancer treatment
Our website is dedicated to providing you with up-to-date and on-target information about current tumor treatments available in China. Free feel to get a cancer treatment option from us, please contact us & like us on facebook to get update news
Mr. Graham. 65 years old, came to China after 3 years of treatment in Australia. The local doctors said they could not do anything more for him. He was diagnosed with lymphoma in the middle of chest. Therefore, both radiotherapy and surgery are not suitable for him. Besides, his immune system was too weak to tolerate the serious side effects of intense chemotherapy.
Fortunately, he heard about Cancer Therapy China from his friends and hoped that a different kind of treatment can help him improve his condition. After the doctors analysed his medical reports, he started a combined treatment of immunotherapy and cell therapy. After recieving the first course of treatment,the tumors in the middle of the chest shrunk obviously. He was very satisfied with the therapeutic effect and decided to continue recieving another two courses of treatment. He found that the staff in the hospital was fantastic and the doctor was very friendly and very helpful at all time. Let's look forward for his next treatment in the future.
PET scan shows tumor size before and after treatment: 2.1cm VS. 1.5cm
The people who love me have made each of my cancer diagnoses easier to bear. They have helped me understand complicated medical information when I was too anxious to think. They listened to my worries, did my errands when I was too tired to move, and distracted me from my pain with funny cards. Hundreds of people have told me about how their families, friends, and co-workers helped them manage the challenges that cancer brings. Here are some things you can do.
1. Acknowledge our situation.
When you know that we have cancer and you don’t say anything about it, we feel even more isolated and alone. Some people—even family members—are uncomfortable saying anything. They fear that raising the topic is too personal or will make us cry. Believe me, much more harm is done by keeping silent. Just say, "I hear you have had some bad news. I am so sorry. I hope things go well for you." It will mean a lot.
In Aug 2007, 43 year old, Ms. Rosanna Wong presented with vaginal bleeding and leucorrhea. After a series of examinations, she was diagnosed with cervical cancer. Then, she unerwent an operation immediately. Two years later, she experienced abdominal pain, edema, poor appetite, insomnia and other symptoms. Therefore, he recieved chemotherapy and radiotherapy at a local hospital. However, she didn't respond to the treatment.
The results of PET-CT showed that there is presence of metastased foci and hydronephrosis. Then, the doctor suggested that the treatment should be withdrawn immmediately. In Nov 2009, Ms. Wong recieved 2 cycles of DC-CIK biotherapy treatment. After the treatment, the metastasis disapppeared and hydronephrosis vanished. Apart from that, her quality life improved significantly, including increased appetite, improved sleep quality, absence of abdominal pain and edema. Finally, she was discharged from our medical center.
In the early 2011, Mr. Yang underwent a sarcoma surgery on his back. The surgery went smoothly and the sarcoma was removed from his back succussfully. However, there is presence of pulmonary metastases three months later. Then, he recieved chemotherapy to inhibit the growth of the tumors in the lung. What was worse, the tumor on his bakc grew again in two months after the chemotherapy. Then, he recieved several rounds of chemotherapy and became weak gradually, which is attributed to the serious side effects oc chemotherapy, including weight loss, poor appetite and loss of hair.
The Patient is undergoing the treatment of argon-helium knife ( a kind of manimally invasive treatment)
In 2001, Ms. Zhang went to the hospital for a check-up for that she had sufferred from chest pain for a period of time. Then, she was diagnosed with advanced breast cancer and underwent a radical resection of breast. During the rehabilitation period, she also received 3 courses of chemotherapy. Eight years later, on account of continuous coughing, Ms. Zhang went to the hospital again and the doctors found that there is metastased foci in the lung. what was worse, she did not respond the radiotherapy and resistance of chemical drugs also occured. Besides, she also suffered a lot from the serious side effects of treatment, including oral uclers, insomnia and so on.
Mr. Wu was diagnosised at a local clinic with cholangiocellular carcinoma postoperative, hepatitis b virus, hepatitis cirrhosis, splenomegaly.
On July 29th 2009, he has a liver resection under general anesthesia in a hospital in Wuhan + microwave-coagulation. Leaves after right hepatic low differentiation of cholangiocellular carcinoma with Portal vein of liver cirrhosis.
On Sept 3rd, 2009, chemotherapy after surgery in the hospital; same year, September 24th, interventional treatment for hepatocellular carcinoma. Since then, respectively on Nov, 2009, May and July 2010. Received 6 courses of CIK cells treatment, total of 18 transfusions at The People's Liberation Army 309 hospital. The treatment went as expected, no adverse reactions, highly improved the patient’s quality of life. Transfusion tests and comparison of image shows: tumor marker levels decreased significantly, not shown with signs of recurrence and metastasis after 10 months of CIK treatment. Thus, CIK cells therapy shows good prevention of recurrence and metastasis of cancer cells, and improved patient’s immunity, and improved the quality of life.
Mr. Fu, 53 years old from Yantai, Shandong, in year 2002 he was diagnosed with "left renal cell carcinoma", he has received operation of left kidney removal. In March 2008, he was found with lung metastases, during intermittent period used immunosuppressive therapy, but ineffective.
In Aug 2008, Mr. Fu came to the People's Liberation Army 309 Hospital tumor treatment center, with left kidney in renal cell carcinoma after excision of 6 years ago, found with lung metastasis for 5 months. After admission, tumor treatment center provided cell transfusion therapy of 2 courses, with remarkable improvement, stability of pulmonary lesions, and there was no sign of metastasis, and Mr. Yu was discharged on Sept 22.
In Feb 2009, at the follow-up with Mr. Fu, we found that he had taken with traditional Chinese medicine and thymus peptide to enhance his immunity system, with optimistic condition. In April, at another follow-up, he was in a stable condition. And, 6 months later, Mr. Fu came to the International Centre again for the second phase of cell therapy treatment. His quality of life was highly improved with stable condition after the treatment.
Mr. Chaker, a 37 years old Liver cancer patient from Tunisia. He was first diagnosed with heptatocellular carcinoma secondary, a cancer of liver; with chronic hepatits B infection back in 2008. Tumors with size of75mm and 55mm were found in his left liver. A year after surgical removal of the tumors, the doctors found the tumor cells have spread to other part of the liver and his lung. This was while he decided to come to cancertherapychina for his treatment. After the doctors in Beijing carefully examine his condition. He was treated with one session of chemotherapy, cancer target treatment and 12 rounds of DC-CIK immunotherapy. His AFP level has dropped from 35619.4ng/ml to 19373.5ng/ml.
"The treatment I received in cancertherapychina is Different and Better comparing to my previous treatments." In other countries, Mr. Chaker received the standard chemotherapy treatment like most places. In cancertherapychina, he received a combination of treatments: chemotherapy with DC-CIK immunotherapy, and gene therapy. On top of that, there are also other treatments such as cryoablation and traditional chinese herbal therapy and more that are available for him. Although not every treatment is suitable for his condition. He felt like in here, there are wide range of treatment options available depended on a cancer patient's needs which really opens up the possibilities for cancer treatment.
Victor from Russia, has went through a lot of difficulties in the past few years ever since he was diagnosed with prostate cancer in a local hospital in Russia at September 2008. He decided to go to a more promising hospital in Germany to treat his cancer. The surgery went well and the recovery was smooth. However, the therapeutic effect was only temporary. In September 2009, the doctors from a hospital in Germany found that there is presnece of new tumors on his right ureter along with right kidney, adrenal glands and bladder. In November 2009, his CT scan and cystoscopy showed that the tumor inside right bladder was 1cm thick with symptoms of edema and inflammatory responses. And he suffered a lot from these symptoms.
Then, Victor searched for other treatments online that could solve his problem. He came across a news that grab his attention. The news was that the ZMKS international cancer therapy biotechnologies Co. developed a new cancer treatment approach called CIK cell therapy to treat cancer. The result was good and Victor decided to come to China to recieve the treatment.
Nicholas, a 32 year old patient from Romania, was admitted to our medical center on April 2, 2009. Nicholas and his wife Madalina have experienced tremendous ups and downs in the process of search ing for or better and effective treatment. He suffered from Hodgkin’s disease, which is a type of malignant tumor originating from the lymphatic system. What was worse, he was diagnosed with progressive multifocal leukoencephalopathy (PML).
After some setbacks, the couple came to China for the latest treatment in the world. To everyone 's joy, the therapeutic effect is quite satisfactory. During the treatment, Cezar, Nicholas' best friend in China, constantly encouraged him and do him a favor as far as possible. Madalina, Nicholas's wife, also shared their experiences during the treatment at our medical center.
O poveste romaneasca- Povestea dlui Nicolae Florescu
Internati in data de 2 aprilie 2009, Nicolae impreuna sotia sa Madalina, au avut parte de urcusuri si coborasuri ingrozitoare in cautarea unui tratament pentru forma de cancer a lui Niki, un tanar de 32 de ani, din Romania, care sufera de Maladia Hodgkin’s, o forma de cancer limfatic, care in ultimul timp, datorita sistemului imunitar deficitar a fost complicat si agravat cu leucoencefalopatie multifocala progresiva, facuta din cauza activarii virusului JC, asa cum a fost diagnosticat de medicii de la spitalul Rambam din Israel.
Calatorind atat in Israel, iar acum in China la Beijing, tanara familie a cautat prin lume cea mai buna terapie si rezolvare pentru problemele de sanatate ale lui Niki.
Dupa acceptarea si internarea in clinica - CTC (Cancer Therapy China)- cuplul a inceput sa vada rezultate foarte incurajatoare si imbucuratoare ale terapiilor medicale pe care Niki Florescu le-a facut. Pe toata perioada internarii ei au fost ajutati si sprijiniti de bunul prieten al lui Niki - Cezar. In interviul urmator, Madalina va impartasi experienta lor dupa cea de-a treia saptamana de cand se afla internati in clinica noastra.
Ms. D, a patient from Netherland who was fifty-five years old, recieved the combined therapy at our medical center. She was diagnosed with lung adenocarinoma and sufferred from serious chest pain. Then, she came to China for bettter personalized treatment. After receiving a comprehensive treatment, the foci in the lung shrunk and these typical symptoms disapppeared, including chemotherapy, antiangiogenesis therapy and gene therapy. We found that one of the tumors disappeared completely and the other one shrunk significantly after two months of treatment at our medical center for cancer. The changes in imaging documents are illustrated in the following part.
Diagnosis: Small cell lung cancer. A lesion of size 5×3.5 cm was found in the central right lung (Fig. 1).
Treatment: In Aug. 2008, combination Chemotherapy with Cryoablation
Post-therapy status: Three months later, the success of the cryosurgery procedure was clearly confirmed, with the majority of tumor completely absent with no traces in remaining tissues (Fig. 2); five months later, the residual tumor necrosis tissues continued to shrink, and were resorbed down to a size of 1.5 cm across (Fig. 3); six months later, necrotic tissue was absorbed completely with only a little scar tissue left (Fig 4).
In June 2009, CTC unveiled it’s newest therapy: CIK-DC (cytokine-induced killer cells combined with dendritic cells). On its own, CIK is still an excellent tool against cancer: it fights and kills cancer cells systemically, boosts and restores the body’s own immune system (especially after the harsh, depleting effects of chemotherapy), and prevents metastasis and recurrence. What do DC cells do? DC cells give CIK a boost that allows CIK cells to more effectively target the location of cancer cells. Cultured from umbilical cord blood, the DC cells are especially potent at assisting CIK cells to protect the body while killing cancer cells.
In the coming weeks, CTC researchers plan to publicly announce the cutting-edge progress they have made in the application of CIK therapy. In recent research, CIK cells cultured from umbilical cord blood were used in animal trials. In these trials, the new CIK cells effectively killed the cancer cells 80% of the time.
There is still more testing to be done, as animals are quite different than complex human bodies. However, umbilical cord CIK cells are showing great promise in the near future for human application. Dosage can greatly affect effectiveness, and researchers are currently testing variables regarding dosage, time, and interval of injection. Thus far, CTC researchers have successfully used CIK to kill 9 types of cancer:
